KR102051132B1 - 미라베그론 또는 이의 염을 포함하는 방출조절용 약제학적 조성물 - Google Patents

미라베그론 또는 이의 염을 포함하는 방출조절용 약제학적 조성물 Download PDF

Info

Publication number
KR102051132B1
KR102051132B1 KR1020170033944A KR20170033944A KR102051132B1 KR 102051132 B1 KR102051132 B1 KR 102051132B1 KR 1020170033944 A KR1020170033944 A KR 1020170033944A KR 20170033944 A KR20170033944 A KR 20170033944A KR 102051132 B1 KR102051132 B1 KR 102051132B1
Authority
KR
South Korea
Prior art keywords
pharmaceutical composition
mirabegron
peo
present
controlled release
Prior art date
Application number
KR1020170033944A
Other languages
English (en)
Korean (ko)
Other versions
KR20180106185A (ko
Inventor
김수연
김민수
서혜진
박신정
Original Assignee
주식회사 종근당
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 종근당 filed Critical 주식회사 종근당
Priority to KR1020170033944A priority Critical patent/KR102051132B1/ko
Priority to PCT/KR2018/003043 priority patent/WO2018169325A1/ko
Priority to CN201880018616.8A priority patent/CN110446490B/zh
Priority to JP2019548680A priority patent/JP2020510679A/ja
Publication of KR20180106185A publication Critical patent/KR20180106185A/ko
Application granted granted Critical
Publication of KR102051132B1 publication Critical patent/KR102051132B1/ko
Priority to JP2021123899A priority patent/JP2021185139A/ja

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
KR1020170033944A 2017-03-17 2017-03-17 미라베그론 또는 이의 염을 포함하는 방출조절용 약제학적 조성물 KR102051132B1 (ko)

Priority Applications (5)

Application Number Priority Date Filing Date Title
KR1020170033944A KR102051132B1 (ko) 2017-03-17 2017-03-17 미라베그론 또는 이의 염을 포함하는 방출조절용 약제학적 조성물
PCT/KR2018/003043 WO2018169325A1 (ko) 2017-03-17 2018-03-15 미라베그론 또는 이의 염을 포함하는 방출조절용 약제학적 조성물
CN201880018616.8A CN110446490B (zh) 2017-03-17 2018-03-15 包含米拉贝隆或其盐的用于调节释放的药剂学组合物
JP2019548680A JP2020510679A (ja) 2017-03-17 2018-03-15 ミラベグロンまたはその塩を含む放出調節用薬剤学的組成物
JP2021123899A JP2021185139A (ja) 2017-03-17 2021-07-29 ミラベグロンまたはその塩を含む放出調節用薬剤学的組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020170033944A KR102051132B1 (ko) 2017-03-17 2017-03-17 미라베그론 또는 이의 염을 포함하는 방출조절용 약제학적 조성물

Publications (2)

Publication Number Publication Date
KR20180106185A KR20180106185A (ko) 2018-10-01
KR102051132B1 true KR102051132B1 (ko) 2019-12-02

Family

ID=63522330

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020170033944A KR102051132B1 (ko) 2017-03-17 2017-03-17 미라베그론 또는 이의 염을 포함하는 방출조절용 약제학적 조성물

Country Status (4)

Country Link
JP (2) JP2020510679A (zh)
KR (1) KR102051132B1 (zh)
CN (1) CN110446490B (zh)
WO (1) WO2018169325A1 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210112240A (ko) 2020-03-03 2021-09-14 동광제약 주식회사 미라베그론을 포함하는 제어 방출 제제

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021069944A1 (en) * 2019-10-09 2021-04-15 Alvogen Korea Co., Ltd. Pharmaceutical composition comprising mirabegron and process for manufacturing the same
EP4338729A1 (en) 2022-09-19 2024-03-20 Sanovel Ilac Sanayi Ve Ticaret A.S. A tablet comprising mirabegron

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101524164B1 (ko) * 2008-09-30 2015-06-01 아스텔라스세이야쿠 가부시키가이샤 방출 제어 의약 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA99407B (en) * 1998-01-22 1999-07-20 Abbott Lab Extended release tiagabine formulations with reduced side-effects.
ZA200503510B (en) * 2002-11-07 2006-12-27 Yamanouchi Pharma Co Ltd Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient
US20050169992A1 (en) * 2003-12-23 2005-08-04 Frank Jao Methods and dosage forms for increasing solubility of drug compositions for controlled delivery
SA07280459B1 (ar) * 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
JP5849946B2 (ja) * 2010-03-29 2016-02-03 アステラス製薬株式会社 放出制御医薬組成物
US20150031734A1 (en) * 2012-03-30 2015-01-29 Astellas Pharma Inc. Pharmaceutical composition containing mirabegron
CN104602693A (zh) * 2012-08-31 2015-05-06 安斯泰来制药株式会社 口服给药用药物组合物
CN104288116A (zh) * 2014-09-05 2015-01-21 南京华威医药科技开发有限公司 一种米拉贝隆缓释片组合物
KR20170088783A (ko) * 2017-07-07 2017-08-02 지엘팜텍주식회사 미라베그론의 습식과립 조성물
EP3292864A1 (en) * 2017-10-12 2018-03-14 Synthon B.V. Modified release tablet composition comprising mirabegron

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101524164B1 (ko) * 2008-09-30 2015-06-01 아스텔라스세이야쿠 가부시키가이샤 방출 제어 의약 조성물

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210112240A (ko) 2020-03-03 2021-09-14 동광제약 주식회사 미라베그론을 포함하는 제어 방출 제제

Also Published As

Publication number Publication date
KR20180106185A (ko) 2018-10-01
WO2018169325A1 (ko) 2018-09-20
JP2020510679A (ja) 2020-04-09
CN110446490A (zh) 2019-11-12
CN110446490B (zh) 2023-04-04
JP2021185139A (ja) 2021-12-09

Similar Documents

Publication Publication Date Title
WO2009034541A2 (en) Controlled release pharmaceutical dosage forms of trimetazidine
ES2281313T3 (es) Composiciones farmacéuticas que comprenden lercanidipino
ES2622495T3 (es) Composición farmacéutica que contiene un antagonista de canales de calcio de dihidropiridina y método para su preparación
JP2021185139A (ja) ミラベグロンまたはその塩を含む放出調節用薬剤学的組成物
KR101269829B1 (ko) 위체류 약물전달 시스템을 이용한 서방성 제제
JP2012503613A (ja) コンパクト化シナカルセット
KR102479497B1 (ko) 바레니클린 서방성 제제 및 이의 제조 방법
KR102062791B1 (ko) 미라베그론 또는 그의 약제학적으로 허용되는 염을 함유한 방출조절 제제
KR20150002453A (ko) 타다라필 또는 이의 약학적으로 허용가능한 염을 포함하는 저작정 제제
EP2377522B1 (en) Orally disintegrating tablet formulations of mirtazapine and process for preparing the same
KR102206104B1 (ko) 실로도신을 포함하는 과립물, 및 이를 포함하는 약학적 조성물 및 제형
EP2335698B1 (en) Pharmaceutical solid preparation having active ingredients separated by boundary therein
EP3697392B1 (en) Tablets comprising tamsulosin and solifenacin
EP3025707A1 (en) A multilayer tablet comprising metformin and pioglitazone
RU2616263C2 (ru) Таблетка с замедленным высвобождением, содержащая леводропропизин, и способ ее изготовления
JP2023035359A (ja) グアンファシン製剤
CA3190856A1 (en) Solid dosage forms of palbociclib
EP2409685A2 (en) Orally-disintegrating formulations of prasugrel
EP2903593B1 (en) Tablet containing composite with cyclodextrin
CA2520813C (en) Sustained release formulations of alkylene dioxybenzene derivatives useful as 5-ht1a agonists
KR20210096162A (ko) 의약 조성물
CA2420712C (en) Fast release cefuroxime axetil compositions
EP3023094B1 (en) Novel formulation of cilostazol
WO2003075919A1 (fr) Comprime contenant du chlorhydrate de pilsicainide (voie seche)
EP2409701B1 (en) Prasugrel granules with improved stability

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant